Approval for iol models sn60t3, sn60t4 and sn60t5.  The device, as modified, will be marketed under the trade name acrysof toric single-piece natural iol and is indicated for primary implantation in the capsular bag of the eye for visual correction of aphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia, who desire improved spectacle independence for distance vision.